Minerva urology and nephrology
MRI prostate tumor volume predicts the need for systematic biopsies in patients undergoing MRI-targeted biopsy.
Hanna Zurl, Stefan Embacher, Helmut Schöllnast, Emina Talakic, Stephanie Schöpfer-Schwab, Klara Pohl, Lukas Scheipner, Samra Jasarevic, Julia Altziebler, Anna Mangge, Sebastian Mannweiler, Jakob Riedl, Uros Bele, Conrad Leitsmann, Marianne Leitsmann
Published: 202610.23736/S2724-6051.25.06375-X
Abstract
BACKGROUND: Combined transrectal mpMRI-TRUS targeted (TB) and systematic biopsy (SB) is widely used to diagnose prostate cancer (PCa). However, SB may be omitted in a subset of patients with minimal risk of missing clinically significant prostate can…
Preview only. Read the full abstract at the source